Medicaid high volume prescriptions are mostly branded products, Walsh America profile finds.
BRANDED PRODUCTS ARE SIX OF TOP 10 MEDICAID SCRIPTS, according to Walsh America Source data, which encompasses prescriber-level data from all channels of distribution. The Source data are a composite of data from 1993 to 1995 across a "majority" of states, Phoenix-based market information firm Walsh America says.
You may also be interested in...
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011
FDA appears headed for a showdown with clinicians and the pharmaceutical industry over the proposed new clinical trial endpoints for acute bacterial skin and skin structure infections, the guidance's approach for justifying a non-inferiority margin and proposed changes in the types of patients that should be enrolled in trials
Specialty drug maker Shire has quietly begun scouting deals with a brand-new $50 million venture fund, the latest of several in-house investment arms to launch with their parent company's pipelines, not profits, as the measure of their worth